Better to Be an Agnostic than a Believer (at Least in Pulmonary Fibrosis)
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.202207-1437ed
Abstract: Time flies: almost a decade ago the results of the INPULSIS (Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients) and ASCEND (Efficacy and Safety of Pirfenidone in Patients With… read more here.
Keywords: ipf; methodology; saracatinib; pulmonary fibrosis ... See more keywords
Anti-allergic effect of the Src family kinase inhibitor saracatinib.
Sign Up to like & getrecommendations! Published in 2020 at "Die Pharmazie"
DOI: 10.1691/ph.2020.9949
Abstract: The aim of this study was to evaluate the anti-anaphylactic and anti-allergic potentials of saracatinib, a Src family kinase inhibitor that was already shown to be safe in clinical trials when it was used as… read more here.
Keywords: src family; kinase inhibitor; saracatinib; family kinase ... See more keywords